Joint Formulary & PAD

Autologous human corneal epithelial cells - Ocular burns in adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Associated Icons :
NHSE
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Autologous human corneal epithelial cells
Indication :
Ocular burns in adults
Group Name :
Keywords :
ex-vivo expanded, stem cells, limbal stem cell deficiency, LSCD, physical or chemical burns,
Brand Names Include :
Holoclar
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Autologous human corneal epithelial cells is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Ocular burns in adults.

  • No records returned.

Committee Recommendations (1)

16 Apr 18 - Not Set

These drugs falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication